Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 7, 2005; 11(13): 1976-1980
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.1976
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.1976
Table 4 Main outcome measurements for patients with CHB treated with interferon-α 2a.
| Response outcome | Total | HBeAg positive | Anti-HBe positive | P | |
| Viral response | n | % | % | % | |
| 3rd mo | 47 | 53.4 | 36.3 | 63.6 | <0.01 |
| 6th mo | 38 | 43.1 | 27.2 | 52.7 | <0.05 |
| 12th mo | 26 | 29.5 | 18.1 | 36.3 | >0.1 |
| Biochemical response | |||||
| 3rd mo | 30 | 34.1 | 21.2 | 41.8 | >0.5 |
| 6th mo | 26 | 29.5 | 24.2 | 32.7 | >0.5 |
| 12th mo | 25 | 28.4 | 24.2 | 30.9 | >0.5 |
| Serological response | |||||
| 3rd mo | 4 | 12.1 | 12.1 | – | – |
| 6th mo | 7 | 21.2 | 21.2 | – | – |
| 12th mo | 8 | 24.2 | 24.2 | – | – |
- Citation: Sunbul M, Leblebicioglu H. Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey. World J Gastroenterol 2005; 11(13): 1976-1980
- URL: https://www.wjgnet.com/1007-9327/full/v11/i13/1976.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i13.1976